Wildcat Capital Management, LLC has filed its Form 13F-HR, disclosing equity securities held as of the close of business on September 30, 2026. The filing, signed by General Counsel and Chief Operating Officer Brian J. Rosenblatt on October 28, 2026, lists five distinct positions held by the firm.
The largest position disclosed in the filing is in Allogene Therapeutics Inc., where the firm holds 2,920,787 shares. The second largest holding is Frontier Group Hldgs Inc., with 28,061,351 shares. The remaining three positions are in Figure Technology Solution Cl A, Netskope Inc Cl A, and Procore Technologies Inc, with holdings of 29,299, 65,174, and 3,851 shares, respectively. All positions are listed as sole voting rights.
